Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Most Cited Article

Epi-Drugs and Epi-miRs: Moving Beyond Current Cancer Therapies

Volume:16   Issue:9
Pp: 773-788
Reza Salarinia, Amirhossein Sahebkar, Mostafa Peyvandi, Hamid Reza Mirzaei, Mahmoud Reza Jaafari, Maryam Matbou Riahi, Hamed Ebrahimnejad, Javid Sadri Nahand, Jamshid Hadjati, Mobina Ostadi Asrami, Sara Fadaei, Rasoul Salehi and Hamed Mirzaei
DOI: 10.2174/1568009616666151207110143

The SCF-type E3 Ubiquitin Ligases as Cancer Targets

Volume:16   Issue:2
Pp: 119-129
Kyoko Kitagawa and Masatoshi Kitagawa
DOI: 10.2174/1568009616666151112122231

Indoleamine 2,3-dioxygenase (IDO): Biology and Target in Cancer Immunotherapies

Volume:16   Issue:9
Pp: 755-764
Senthamil R. Selvan, John P. Dowling, William K. Kelly and Jianqing Lin
DOI: 10.2174/1568009615666151030102250

Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma

Volume:16   Issue:3
Pp: 261-274
Marilù Fanelli, Claudia Maria Hattinger, Serena Vella, Elisa Tavanti, Francesca Michelacci, Beth Gudeman, Daryl Barnett, Piero Picci and Massimo Serra
DOI: 10.2174/1568009616666151106120434

Targeting Tumors with Small Molecule Peptides

Volume:16   Issue:6
Pp: 489-508
Andrew G. Cheetham, Daniel Keith, Pengcheng Zhang, Ran Lin, Hao Su and Honggang Cui
DOI: 10.2174/1568009616666151130214646

Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy

Volume:16   Issue:2
Pp: 136-146
Nobumichi Ohoka, Norihito Shibata, Takayuki Hattori and Mikihiko Naito
DOI: 10.2174/1568009616666151112122502

Regulation of Epithelial-Mesenchymal Transition by E3 Ubiquitin Ligases and Deubiquitinase in Cancer

Volume:16   Issue:2
Pp: 110-118
Yasumichi Inoue, Yuka Itoh, Koichi Sato, Fumihiro Kawasaki, Chihiro Sumita, Takahito Tanaka, Daisuke Morishita and Hidetoshi Hayashi
DOI: 10.2174/1568009616666151112122126

S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway

Volume:16   Issue:5
Pp: 455-465
Zongliang Lu, Rui Zhou, Ya Kong, Jiajia Wang, Wanyuan Xia, Jing Guo, Jie Liu, Hailan Sun, Kai Liu, Jian Yang, Mantian Mi and Hongxia Xu
DOI: 10.2174/1568009616666151207105720

MicroRNA as Regulators of Cancer Stem Cells and Chemoresistance in Colorectal Cancer

Volume:16   Issue:9
Pp: 738-754
Xiaoming Liu, Qi Fu, Yong Du, Yinxue Yang and William C. Cho
DOI: 10.2174/1568009616666151118114759

CD20-based Immunotherapy of B-cell Derived Hematologic Malignancies

Volume:17   Issue:5
Pp: 423-444
Dariush Shanehbandi, Jafar Majidi*, Tohid Kazemi*, Behzad Baradaran and Leili Aghebati-Maleki
DOI: 10.2174/1568009617666170109151128

Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer

Volume:16   Issue:5
Pp: 429-441
Lingyun Zhang, Lubna Nadeem, Kristin Connor and Guoxiong Xu
DOI: 10.2174/1568009616666160404121105

Advances in Synergistic Combinations of Chinese Herbal Medicine for the Treatment of Cancer open access plus

Volume:16   Issue:4
Pp: 346-356
Xue-Qing Hu, Yang Sun, Eric Lau, Ming Zhao and Shi-Bing Su
DOI: 10.2174/1568009616666151207105851

Targeting Signaling Pathways in Chronic Lymphocytic Leukemia

Volume:16   Issue:8
Pp: 669-688
Alice F. Muggen, Simar P. Singh, Rudi W. Hendriks and Anton W. Langerak
DOI: 10.2174/1568009616666160408145623

Targeted Inhibition of Rictor/mTORC2 in Cancer Treatment: A New Era after Rapamycin

Volume:16   Issue:4
Pp: 288-304
Zhipeng Zou, Juan Chen, Jun Yang and Xiaochun Bai
DOI: 10.2174/1568009616666151113120830

miR-137 Suppresses the Phosphorylation of AKT and Improves the Dexamethasone Sensitivity in Multiple Myeloma Cells Via Targeting MITF

Volume:16   Issue:9
Pp: 807-817
Benping Zhang, Ling Ma, Jia Wei, Jingyu Hu, Zichu Zhao, Youping Wang, Yan Chen and Fei Zhao
DOI: 10.2174/1568009616666160203114140

OncomicroRNAs-Mediated Tumorigenesis: Implication in Cancer Diagnosis and Targeted Therapy

Volume:17   Issue:1
Pp: 40-47
Nana Zheng, Ping Yang, Zhiwei Wang and Quansheng Zhou
DOI: 10.2174/1568009616666160216130608